112 completed, 30 recruiting, 28 terminated, 21 active not recruiting. 220 Phase 1, 94 Phase 2.
Follow Hemoglobinopathies: new trials by email Literature Review of Hemoglobinopathies trials Research Report on Hemoglobinopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Buprenorphine for the Management of Pain in Children With Sickle Cell Disease Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis | Phase 1 | Not yet recruiting | Natasha Archer | 25 | 2027-01-01 | 2026-11-04 |
| Minocycline In Neurocognitive Outcomes - Sickle Cell Disease Minocycline, Placebo - Sickle Cell Disease, Cognitive Impairment | Phase 1 | Not yet recruiting | University of Cincinnati | 30 | 2026-12-01 | 2026-11-03 |
| Feasibility and Acceptability of Amani Amani - Sickle Cell Disease | Phase 1 / Phase 2 | Not yet recruiting | Massachusetts General Hospital | 40 | 2026-11-01 | 2026-08-07 |
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein, Sequencing Assay for Variant rs114518452 - Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | Phase 1 | Recruiting | Daniel Bauer | 5 | 2026-08-01 | 2026-10-21 |
| Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease VAS-101 - Sickle Cell Disease, Hemolytic Anemia | Phase 1 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 25 | 2026-07-31 | 2026-10-21 |
| Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors Total Body Irradiation, Alemtuzumab, Abatacept - Sickle Cell Disease, Beta-thalassemia | Phase 1 / Phase 2 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 90 | 2026-07-08 | 2026-10-13 |
| Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease Ruxolitinib - Sickle Cell Disease, Hematopoetic Stem Cell Transplant | Phase 1 / Phase 2 | Recruiting | Arkansas Children's Hospital Research Institute | 24 | 2026-06-08 | 2026-06-04 |
| STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE Plerixafor Dose Escalation - Sickle Cell Disease | Phase 1 / Phase 2 | Not yet recruiting | Hospital Israelita Albert Einstein | 12 | 2026-06-01 | 2026-01-14 |
| Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children | Phase 1 / Phase 2 | Recruiting | Children's Hospital Medical Center, Cincinnati | 250 | 2026-05-13 | 2026-07-16 |
| Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA. DREAM01 drug product, anti-inflammatory therapy - Sickle Cell Disease | Phase 1 / Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | 15 | 2026-02-25 | 2026-03-04 |
| A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) DISC-3405 - Sickle Cell Disease | Phase 1 | Recruiting | Disc Medicine, Inc | 24 | 2026-01-06 | 2026-11-13 |
| Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease Pociredir - Sickle Cell Disease | Phase 1 | Terminated | Fulcrum Therapeutics | 13 | 2025-12-13 | 2026-06-18 |
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein, Sequencing Assay for Variant rs114518452 - Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | Phase 1 | Recruiting | Daniel Bauer | 10 | 2025-12-01 | 2026-02-03 |
| Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease Extended-Release Methylphenidate - Sickle Cell Disease, Executive Dysfunction | Phase 1 | Recruiting | St. Jude Children's Research Hospital | 72 | 2025-11-25 | 2026-09-09 |
| Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease CRISPR_SCD001 - Sickle Cell Disease | Phase 1 / Phase 2 | Recruiting | Mark Walters, MD | 9 | 2025-08-22 | 2026-10-20 |
| A Phase I Study of SNH-119014 in Healthy Volunteers SNH-119014, Placebo - Hemoglobinopathy | Phase 1 | Recruiting | ScinnoHub Pharmaceutical Co., Ltd. | 96 | 2025-06-27 | 2025-07-25 |
| A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants Etavopivat, Moxifloxacin, Placebo - Healthy Volunteers, Sickle Cell Disease | Phase 1 | Completed | Novo Nordisk A/S | 33 | 2025-06-09 | 2026-01-02 |
| 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD) 131I-apamistmab, Sirolimus, Campath - Sickling Disorder Due to Hemoglobin S | Phase 1 | Recruiting | Columbia University | 24 | 2025-04-28 | 2026-06-10 |
| ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia ALS20 - Beta-Thalassemia | Phase 1 / Phase 2 | Active not recruiting | Children's Hospital of Philadelphia | 12 | 2025-04-14 | 2026-10-29 |
| Cannabidiol in Sickle Cell Disease Cannabidiol, Placebo - Sickle Cell Disease | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 52 | 2025-04-03 | 2025-06-25 |
Showing 20 of 220. Sign in to see all of them.
Anemia, Sickle Cell (182) · beta-Thalassemia (35) · Thalassemia (33) · Anemia (10) · Anemia, Diamond-Blackfan (10) · Vaso-Occlusive Crises (9) · Hematologic Diseases (8) · Anemia, Aplastic (7) · Genetic Diseases, Inborn (7) · Anemia, Hemolytic (6) · Bone Marrow Failure Disorders (6) · Hemoglobin SC Disease (6) · Hypertension, Pulmonary (6) · Sickle Cell Trait (6)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (220) · Hemic and Lymphatic Diseases (220) · Genetic Diseases, Inborn (213) · Anemia, Hemolytic, Congenital (212) · Hematologic Diseases (212) · Anemia, Hemolytic (210) · Anemia (207) · Thalassemia (31) · Pathological Conditions, Signs and Symptoms (25) · Nutritional and Metabolic Diseases (18) · Immune System Diseases (16) · Pathologic Processes (16) · Metabolic Diseases (15) · Bone Marrow Diseases (14)
Hydroxyurea (16) · Alemtuzumab (14) · Sirolimus (13) · fludarabine (9) · Cyclophosphamide (7) · plerixafor (7) · voxelotor (6) · Abatacept (5) · Hematopoietic Stem Cell Transplantation (5) · Mycophenolic Acid (5) · fludarabine phosphate (5) · Busulfan (4) · Melphalan (4) · Stem Cell Transplantation (4) · Tacrolimus (4)
National Heart, Lung, and Blood Institute (NHLBI) (17) · Pfizer (6) · St. Jude Children's Research Hospital (5) · Children's Hospital Medical Center, Cincinnati (4) · City of Hope Medical Center (4) · Emory University (4) · Global Blood Therapeutics (4) · Novo Nordisk A/S (4) · Washington University School of Medicine (4) · Assistance Publique - Hôpitaux de Paris (3) · Bellicum Pharmaceuticals (3) · Children's Hospital Los Angeles (3) · Children's Hospital of Philadelphia (3) · Fulcrum Therapeutics (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3)
United States (163) · China (12) · Canada (9) · United Kingdom (9) · France (8) · Italy (6) · Lebanon (5) · Nigeria (5) · Thailand (4) · Australia (3) · Brazil (3) · Jamaica (3) · Kenya (3) · Netherlands (3) · Spain (3)
John F Tisdale, M.D. (10) · Carla Washington, PhD (3) · Swee Lay Thein, M.D. (3) · A O Dosunmu, M.D. (2) · Abdullah Kutlar, MD (2) · Courtney D Fitzhugh, M.D. (2) · Courtney F Joseph, M.D. (2) · Diane George, MD (2) · Shalini Shenoy, MD (2)
PMID 36240296, PMID 42133908, PMID 24916507, PMID 26348869, PMID 26589907, PMID 34175041, PMID 36860093, PMID 36975201, PMID 37254256, PMID 38866240, PMID 40891510, PMID 41871072, PMID 15592491, PMID 16990602, PMID 17536019, PMID 17620452, PMID 18026148, PMID 18439858, PMID 18500373, PMID 18550886, PMID 19840322, PMID 20007560, PMID 20117846, PMID 20644039, PMID 20732454, PMID 20797926, PMID 20936416, PMID 21477202, PMID 21742281, PMID 22875626, PMID 22887019, PMID 23377438, PMID 23416852, PMID 23973010, PMID 24296492, PMID 24988449, PMID 25058217, PMID 25222041, PMID 25701866, PMID 25938131, PMID 26021713, PMID 26275071, PMID 26719803, PMID 27862048, PMID 28096387, PMID 28152086, PMID 28249145, PMID 28331623, PMID 28880867, PMID 28884840
2014 (3), 1RC2HL101367-01 (1), 1ZIAHL006149-01 (1), 2017 (1), 2019 (1), 2023 (1), 2025 (1), K23HL133446 (1), K23HL146904 (1), K24AT009893 (1), P20GM109021 (1), P30CA033572 (1), R01DK055463 (1), R01HL154629 (1), R01NS045948 (1)